1887
Research Open Access
Like 0

Abstract

Introduction

It is unclear whether high-dose influenza vaccine (HD) is more effective at reducing mortality among seniors.

Aim

This study aimed to evaluate the relative vaccine effectiveness (rVE) of HD.

Methods

We linked electronic medical record databases in the Veterans Health Administration (VHA) and Medicare administrative files to examine the rVE of HD vs standard-dose influenza vaccines (SD) in preventing influenza/pneumonia-associated and cardiorespiratory mortality among VHA-enrolled veterans 65 years or older during the 2012/13, 2013/14 and 2014/15 influenza seasons. A multivariable Cox proportional hazards model was performed on matched recipients of HD vs SD, based on vaccination time, location, age, sex, ethnicity and VHA priority level.

Results

Among 569,552 person-seasons of observation, 207,574 (36%) were HD recipients and 361,978 (64%) were SD recipients, predominantly male (99%) and white (82%). Pooling findings from all three seasons, the adjusted rVE estimate of HD vs SD during the high influenza periods was 42% (95% confidence interval (CI): 24–59) against influenza/pneumonia-associated mortality and 27% (95% CI: 23–32) against cardiorespiratory mortality. Residual confounding was evident in both early and late influenza periods despite matching and multivariable adjustment. Excluding individuals with high 1-year predicted mortality at baseline reduced the residual confounding and yielded rVE of 36% (95% CI: 10–62) and 25% (95% CI: 12–38) against influenza/pneumonia-associated and cardiorespiratory mortality, respectively. These were confirmed by results from two-stage residual inclusion estimations.

Discussion

The HD was associated with a lower risk of influenza/pneumonia-associated and cardiorespiratory death in men during the high influenza period.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.19.1900401
2020-05-14
2020-08-10
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2020.25.19.1900401
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/19/eurosurv-25-19-4.html?itemId=/content/10.2807/1560-7917.ES.2020.25.19.1900401&mimeType=html&fmt=ahah

References

  1. Young-Xu Y, van Aalst R, Russo E, Lee JK, Chit A. The annual burden of seasonal influenza in the US veterans affairs population. PLoS One. 2017;12(1):e0169344.  https://doi.org/10.1371/journal.pone.0169344  PMID: 28046080 
  2. Centers for Disease Control and Prevention. Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014. MMWR Recomm Rep. 2013;62(RR-07):1-43. PMID: 24048214 
  3. Thompson WW, Shay DK, Weintraub E, Brammer L, Bridges CB, Cox NJ, et al. Influenza-associated hospitalizations in the United States. JAMA. 2004;292(11):1333-40.  https://doi.org/10.1001/jama.292.11.1333  PMID: 15367555 
  4. Thompson WW, Shay DK, Weintraub E, Brammer L, Cox N, Anderson LJ, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA. 2003;289(2):179-86.  https://doi.org/10.1001/jama.289.2.179  PMID: 12517228 
  5. Thompson WW, Moore MR, Weintraub E, Cheng PY, Jin X, Bridges CB, et al. Estimating influenza-associated deaths in the United States. Am J Public Health. 2009;99(S2) Suppl 2;S225-30.  https://doi.org/10.2105/AJPH.2008.151944  PMID: 19797736 
  6. Monto AS, Ansaldi F, Aspinall R, McElhaney JE, Montaño LF, Nichol KL, et al. Influenza control in the 21st century: Optimizing protection of older adults. Vaccine. 2009;27(37):5043-53.  https://doi.org/10.1016/j.vaccine.2009.06.032  PMID: 19559118 
  7. DiazGranados CA, Dunning AJ, Jordanov E, Landolfi V, Denis M, Talbot HK. High-dose trivalent influenza vaccine compared to standard dose vaccine in elderly adults: safety, immunogenicity and relative efficacy during the 2009-2010 season. Vaccine. 2013;31(6):861-6.  https://doi.org/10.1016/j.vaccine.2012.12.013  PMID: 23261045 
  8. Gravenstein S, Davidson HE, Taljaard M, Ogarek J, Gozalo P, Han L, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccination on numbers of US nursing home residents admitted to hospital: a cluster-randomised trial. Lancet Respir Med. 2017;5(9):738-46.  https://doi.org/10.1016/S2213-2600(17)30235-7  PMID: 28736045 
  9. DiazGranados CA, Dunning AJ, Kimmel M, Kirby D, Treanor J, Collins A, et al. Efficacy of high-dose versus standard-dose influenza vaccine in older adults. N Engl J Med. 2014;371(7):635-45.  https://doi.org/10.1056/NEJMoa1315727  PMID: 25119609 
  10. DiazGranados CA, Robertson CA, Talbot HK, Landolfi V, Dunning AJ, Greenberg DP. Prevention of serious events in adults 65 years of age or older: A comparison between high-dose and standard-dose inactivated influenza vaccines. Vaccine. 2015;33(38):4988-93.  https://doi.org/10.1016/j.vaccine.2015.07.006  PMID: 26212007 
  11. Richardson DM, Medvedeva EL, Roberts CB, Linkin DRCenters for Disease Control and Prevention Epicenter Program. Comparative effectiveness of high-dose versus standard-dose influenza vaccination in community-dwelling veterans. Clin Infect Dis. 2015;61(2):171-6.  https://doi.org/10.1093/cid/civ261  PMID: 25829001 
  12. Izurieta HS, Thadani N, Shay DK, Lu Y, Maurer A, Foppa IM, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis. Lancet Infect Dis. 2015;15(3):293-300.  https://doi.org/10.1016/S1473-3099(14)71087-4  PMID: 25672568 
  13. Shay DK, Chillarige Y, Kelman J, Forshee RA, Foppa IM, Wernecke M, et al. Comparative effectiveness of high-dose versus standard-dose influenza vaccines among US Medicare beneficiaries in preventing postinfluenza deaths during 2012-2013 and 2013-2014. J Infect Dis. 2017;215(4):510-7.  https://doi.org/10.1093/infdis/jiw641  PMID: 28329311 
  14. Young-Xu Y, Van Aalst R, Mahmud SM, Rothman KJ, Snider JT, Westreich D, et al. Relative vaccine effectiveness of high-dose versus standard-dose influenza vaccines among veterans health administration patients. J Infect Dis. 2018;217(11):1718-27.  https://doi.org/10.1093/infdis/jiy088  PMID: 29452380 
  15. Young-Xu Y, Snider JT, van Aalst R, Mahmud SM, Thommes EW, Lee JKH, et al. Analysis of relative effectiveness of high-dose versus standard-dose influenza vaccines using an instrumental variable method. Vaccine. 2019;37(11):1484-90.  https://doi.org/10.1016/j.vaccine.2019.01.063  PMID: 30745146 
  16. National Center for Health Statistics. National Death Index user’s guide. Hyattsville: Centers for Disease Control and Prevention. 2013. Available from: https://www.cdc.gov/nchs/data/ndi/NDI_Users_Guide.pdf
  17. International Classification of Diseases. Tenth Revision (ICD-10). Atlanta; CDC. [Accessed: 9 May 2020]. Available from: https://www.cdc.gov/nchs/icd/icd10.htm
  18. Centers for Disease Control and Prevention (CDC). U.S. Influenza Surveillance System: Purpose and Methods. Atlanta; CDC.[Accessed: 7 Jul 2018]. Available from: http://www.cdc.gov/flu/weekly/overview.htm
  19. Campitelli MA, Rosella LC, Stukel TA, Kwong JC. Influenza vaccination and all-cause mortality in community-dwelling elderly in Ontario, Canada, a cohort study. Vaccine. 2010;29(2):240-6.  https://doi.org/10.1016/j.vaccine.2010.10.049  PMID: 21044667 
  20. Petersen LA, Byrne MM, Daw CN, Hasche J, Reis B, Pietz K. Relationship between clinical conditions and use of Veterans Affairs health care among Medicare-enrolled veterans. Health Serv Res. 2010;45(3):762-91.  https://doi.org/10.1111/j.1475-6773.2010.01107.x  PMID: 20403056 
  21. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613-9.  https://doi.org/10.1016/0895-4356(92)90133-8  PMID: 1607900 
  22. Elixhauser A, Steiner C, Harris DR, Coffey RM. Comorbidity measures for use with administrative data. Med Care. 1998;36(1):8-27.  https://doi.org/10.1097/00005650-199801000-00004  PMID: 9431328 
  23. Wang L, Porter B, Maynard C, Evans G, Bryson C, Sun H, et al. Predicting risk of hospitalization or death among patients receiving primary care in the Veterans Health Administration. Med Care. 2013;51(4):368-73.  https://doi.org/10.1097/MLR.0b013e31827da95a  PMID: 23269113 
  24. Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661-79.  https://doi.org/10.1002/sim.6607  PMID: 26238958 
  25. Fiore AE, Bridges CB, Katz JM, Cox NJ. Inactivated influenza vaccines. In: Vaccines. 6th ed. Philadelphia: Elsevier Inc. 2012:257-92.
  26. Heckman JJ, Robb R Jr. Alternative methods for evaluating the impact of interventions: An overview. J Econom. 1985;30(1-2):239-67.  https://doi.org/10.1016/0304-4076(85)90139-3 
  27. Simonsen L, Taylor RJ, Viboud C, Miller MA, Jackson LA. Mortality benefits of influenza vaccination in elderly people: an ongoing controversy. Lancet Infect Dis. 2007;7(10):658-66.  https://doi.org/10.1016/S1473-3099(07)70236-0  PMID: 17897608 
  28. Centers for Disease Control and Prevention (CDC). Influenza activity--United States, 2012-13 season and composition of the 2013-14 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2013;62(23):473-9. PMID: 23760189 
  29. Appiah GD, Blanton L, D’Mello T, Kniss K, Smith S, Mustaquim D, et al. Centers for Disease Control and Prevention (CDC). Influenza activity - United States, 2014-15 season and composition of the 2015-16 influenza vaccine. MMWR Morb Mortal Wkly Rep. 2015;64(21):583-90. PMID: 26042650 
  30. Epperson S, Blanton L, Kniss K, Mustaquim D, Steffens C, Wallis T, et al. Influenza Division, National Center for Immunization and Respiratory Diseases, CDC. Influenza activity - United States, 2013-14 season and composition of the 2014-15 influenza vaccines. MMWR Morb Mortal Wkly Rep. 2014;63(22):483-90. PMID: 24898165 
  31. Centers for Disease Control and Prevention (CDC). Influenza (flu): Past seasons vaccine effectiveness estimates. Atlanta: CDC. [Accessed: 28 Oct 2019]. Available from: https://www.cdc.gov/flu/vaccines-work/past-seasons-estimates.html
  32. Olubowale OT, Safford MM, Brown TM, Durant RW, Howard VJ, Gamboa C, et al. Comparison of expert adjudicated coronary heart disease and cardiovascular disease mortality with the national death index: results from the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study. J Am Heart Assoc. 2017;6(5):e004966.  https://doi.org/10.1161/JAHA.116.004966  PMID: 28468785 
  33. Robison SG, Thomas AR. Assessing the effectiveness of high-dose influenza vaccine in preventing hospitalization among seniors, and observations on the limitations of effectiveness study design. Vaccine. 2018;36(45):6683-7.  https://doi.org/10.1016/j.vaccine.2018.09.050  PMID: 30287157 
  34. Rogers WH, Kazis LE, Miller DR, Skinner KM, Clark JA, Spiro A 3rd, et al. Comparing the health status of VA and non-VA ambulatory patients: the veterans’ health and medical outcomes studies. J Ambul Care Manage. 2004;27(3):249-62.  https://doi.org/10.1097/00004479-200407000-00009  PMID: 15287215 
/content/10.2807/1560-7917.ES.2020.25.19.1900401
Loading

Data & Media loading...

Supplementary data

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error